ICU Medical Pre-Tax Profit Margin 2010-2025 | ICUI
ICU Medical pre-tax profit margin from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| ICU Medical Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-03-31 | $2.42B | $-0.04B | -1.69% |
| 2024-12-31 | $2.38B | $-0.07B | -2.81% |
| 2024-09-30 | $2.34B | $-0.11B | -4.79% |
| 2024-06-30 | $2.30B | $-0.10B | -4.30% |
| 2024-03-31 | $2.26B | $-0.10B | -4.52% |
| 2023-12-31 | $2.26B | $-0.08B | -3.45% |
| 2023-09-30 | $2.25B | $-0.06B | -2.76% |
| 2023-06-30 | $2.29B | $-0.08B | -3.40% |
| 2023-03-31 | $2.31B | $-0.07B | -3.12% |
| 2022-12-31 | $2.28B | $-0.11B | -5.00% |
| 2022-09-30 | $2.04B | $-0.07B | -3.43% |
| 2022-06-30 | $1.78B | $-0.01B | -0.62% |
| 2022-03-31 | $1.54B | $0.04B | 2.66% |
| 2021-12-31 | $1.32B | $0.12B | 9.34% |
| 2021-09-30 | $1.30B | $0.13B | 10.03% |
| 2021-06-30 | $1.28B | $0.12B | 9.23% |
| 2021-03-31 | $1.26B | $0.10B | 8.25% |
| 2020-12-31 | $1.27B | $0.10B | 7.63% |
| 2020-09-30 | $1.27B | $0.09B | 6.95% |
| 2020-06-30 | $1.26B | $0.10B | 7.57% |
| 2020-03-31 | $1.26B | $0.10B | 8.07% |
| 2019-12-31 | $1.27B | $0.12B | 9.08% |
| 2019-09-30 | $1.29B | $0.08B | 6.36% |
| 2019-06-30 | $1.31B | $0.05B | 3.82% |
| 2019-03-31 | $1.36B | $0.05B | 3.83% |
| 2018-12-31 | $1.40B | $0.02B | 1.64% |
| 2018-09-30 | $1.43B | $0.08B | 5.25% |
| 2018-06-30 | $1.45B | $0.08B | 5.47% |
| 2018-03-31 | $1.42B | $0.01B | 0.71% |
| 2017-12-31 | $1.29B | $0.05B | 4.02% |
| 2017-09-30 | $1.02B | $0.03B | 2.55% |
| 2017-06-30 | $0.77B | $0.04B | 5.69% |
| 2017-03-31 | $0.54B | $0.11B | 19.89% |
| 2016-12-31 | $0.38B | $0.09B | 22.37% |
| 2016-09-30 | $0.37B | $0.08B | 22.46% |
| 2016-06-30 | $0.36B | $0.09B | 23.69% |
| 2016-03-31 | $0.35B | $0.08B | 23.71% |
| 2015-12-31 | $0.34B | $0.07B | 20.53% |
| 2015-09-30 | $0.33B | $0.07B | 20.85% |
| 2015-06-30 | $0.32B | $0.05B | 16.46% |
| 2015-03-31 | $0.32B | $0.04B | 12.93% |
| 2014-12-31 | $0.31B | $0.04B | 12.94% |
| 2014-09-30 | $0.31B | $0.04B | 13.68% |
| 2014-06-30 | $0.31B | $0.05B | 15.65% |
| 2014-03-31 | $0.31B | $0.05B | 16.29% |
| 2013-12-31 | $0.31B | $0.05B | 16.88% |
| 2013-09-30 | $0.32B | $0.06B | 18.18% |
| 2013-06-30 | $0.32B | $0.06B | 18.93% |
| 2013-03-31 | $0.32B | $0.06B | 20.00% |
| 2012-12-31 | $0.32B | $0.06B | 19.87% |
| 2012-09-30 | $0.31B | $0.07B | 22.58% |
| 2012-06-30 | $0.31B | $0.07B | 21.31% |
| 2012-03-31 | $0.31B | $0.07B | 21.24% |
| 2011-12-31 | $0.30B | $0.07B | 21.93% |
| 2011-09-30 | $0.30B | $0.06B | 18.39% |
| 2011-06-30 | $0.30B | $0.06B | 18.73% |
| 2011-03-31 | $0.29B | $0.05B | 18.62% |
| 2010-12-31 | $0.28B | $0.05B | 16.96% |
| 2010-09-30 | $0.28B | $0.04B | 15.22% |
| 2010-06-30 | $0.25B | $0.04B | 14.17% |
| 2010-03-31 | $0.24B | $0.03B | 13.87% |
| 2009-12-31 | $0.23B | $0.04B | 16.23% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.218B | $2.382B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.485B | 27.83 |
| Boston Scientific (BSX) | United States | $154.809B | 38.76 |
| Stryker (SYK) | United States | $144.946B | 30.31 |
| EssilorLuxottica (ESLOY) | France | $134.105B | 0.00 |
| Medtronic (MDT) | Ireland | $108.260B | 15.35 |
| Haleon (HLN) | United Kingdom | $50.025B | 28.46 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.059B | 0.00 |
| ResMed (RMD) | United States | $36.038B | 27.07 |
| GE HealthCare Technologies (GEHC) | United States | $31.860B | 15.13 |
| Agilent Technologies (A) | United States | $31.051B | 20.51 |
| Terumo (TRUMY) | Japan | $27.450B | 35.65 |
| Insulet (PODD) | United States | $22.837B | 89.64 |
| Koninklijke Philips (PHG) | Netherlands | $22.023B | 15.83 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.348B | 11.78 |
| Baxter (BAX) | United States | $15.616B | 11.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.578B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.204B | 21.59 |
| Lantheus Holdings (LNTH) | United States | $5.198B | 13.11 |
| Prestige Consumer Healthcare (PBH) | United States | $4.172B | 18.64 |
| Perrigo (PRGO) | Ireland | $3.700B | 9.38 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.362B | 14.64 |
| Envista Holdings (NVST) | United States | $2.820B | 23.44 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| QuidelOrtho (QDEL) | United States | $2.000B | 13.76 |
| LeMaitre Vascular (LMAT) | United States | $1.841B | 41.16 |
| AtriCure (ATRC) | United States | $1.647B | 0.00 |
| Neogen (NEOG) | United States | $1.350B | 17.28 |
| Acuren (TIC) | United States | $1.305B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.223B | 12.41 |
| Kestra Medical Technologies (KMTS) | United States | $1.186B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.169B | 26.29 |
| BioLife Solutions (BLFS) | United States | $1.049B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.942B | 12.05 |
| InMode (INMD) | Israel | $0.898B | 9.05 |
| CeriBell (CBLL) | United States | $0.634B | 0.00 |
| Evolus (EOLS) | United States | $0.618B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.573B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.554B | 0.00 |
| Owens & Minor (OMI) | United States | $0.531B | 4.40 |
| Valneva SE (VALN) | France | $0.527B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.508B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.436B | 0.00 |
| Surmodics (SRDX) | United States | $0.416B | 0.00 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.338B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.331B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.315B | 11.58 |
| Aurora Cannabis (ACB) | Canada | $0.293B | 52.20 |
| Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.267B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Verano Holdings (VRNOF) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.237B | 10.78 |
| Biote (BTMD) | United States | $0.212B | 5.95 |
| Brainsway (BWAY) | Israel | $0.196B | 52.00 |
| OraSure Technologies (OSUR) | United States | $0.190B | 0.00 |
| Quanterix (QTRX) | United States | $0.187B | 0.00 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Omeros (OMER) | United States | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.179B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.176B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.173B | 14.11 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.07 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.113B | 0.00 |
| Agape ATP (ATPC) | $0.105B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Fonar (FONR) | United States | $0.085B | 10.96 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 0.00 |
| United Health Products (UEEC) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.44 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 32.29 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |